| 112 | 1 | 32 |
| 下载次数 | 被引频次 | 阅读次数 |
<正> 免疫药物的研究在70年代已广泛开展,到80年代达到了高潮,无论在免疫增强剂和免疫抑制剂两个方面均有重大进展,是生物学科的研究热点。本文将概要介绍这个领域的近年进展。
Abstract：1 Azums I. Review. inducer of cytokinea in vivo: overview of field and romurtide experieuce. Int. Immunopharmac. 1992; 14(3) : 487
2 Azums I. Development of the cytokine inducer romurtide. experimental studies and clinical application. Trends Pharmcal Sci 1992, 13(12) : 425
3 Yamasaki K, S. Synergistic induction of lymphokine (IL-2) activated killer activity by IL-2 and the polysaccharide lentinan, and therapy of spontaneous pulmonary metastases. Cancer Immunol Immunother 1989;29(2) : 87
4 Shonya Arinaga, et al. Enhanced induction of lymphokine activated killer activity after lentinan administration in patients with gastric carcinoma. Int J Immunopharmac. 1992; 14(4) : 535
5 Hadden JW, Giner SA. Metyl inosine monophoaphate (MIMP), a new purinc immunoodulator for HIV infection. Int J Immunopharmac. 1991; 1: 49
6 Hadden JW, Ongradi J, et al. Methyl inosine monophosphate, A potential immunotherapeutic for early humman immunodeficiency virus (HIV) infection. Int J Immunopharmac 1992; 14(4) : 555
7 Pope BL, Chourmouzis E, et al. In vivo enhancement of murine Natural Killer cell activity by 7-allyl-8-oxnguanosine (Loxoribine). Int J Immunopharmac 1992; 14(8) : 1375
8 Smee DF, Alaghamandan HA, et al. Broad spectrum in vivoantiviral activity of 7-thia-8-oxoguanosine, a novel immunopotentiating agent. Antimicro Agents Chemother 1989; 33(9) : 1487
9 Cramer DV. Chapman FA, et al. The effect of a new immunosuppressive drugs, Brequinar Sodium, on heart, liver and kidney allograft regection in the rat. Transplantation 1992; 53(2) : 303
10 Eiras HG, Gramer DV, et al. Correlation of the in vivo and in vitro immunosuppressive activity of Brequinar Sadium. Transplantation Proceedings. 1993; 25(1) : 706
11 Schreiber SL and Crabtree GR. The mechanism of action of cyclosperin A and FK 506． Immunology Today. 1992; 13(4) : 136
12 Schreiber and Pawelec G. Cyclosporine A and FK506 showsimilar immunosuppressive effects on long term in witro T-cell proliferation. Int J Immunopharmac 1993; 15(2) : 93
13 Mataukawa W, Hara S, et al. Effects of a new immunosuppressive agent, FK506, in rats with active heymann nephritis. J Lab Clin Med. 1992; 119(2) : 116
14 Macleod AM, Thomson AW. FK506, an immunosuppressant for the 1990s. Lancet. 1991; 337: 25
15 Badger AM, Swift BA, et al. Beneficial effects of SK & F105685 in rat adjuvant arthritis prophylactic and therapeutic effects on disease papameter progression, Int J Immunopharmac. 1993; 15(3) : 343
16 Badger MV, Schwartz DA, et al. Antiarthritic and suppressor cell inducing activity of azaspiranes, structurefunction relationships of a novel class of immunomodulatory agenta. J Med Chem. 1990; 33(11) : 2963
17 Hiestand PC, Graber M, et al. New cyclosporine derivstire SDZIMM 125: in vitro and in vivo pharmacologic effects and toxicologic evaluation. Transplantation Proceedings. 1993; 25(1) : 691
基本信息:
DOI：10.19577/j.cnki.issn10074406.1994.04.011
中图分类号:R979.5
引用信息:
[1]张罗修.免疫药物的研究动向[J].临床药学,1994(04):32-35.DOI:10.19577/j.cnki.issn10074406.1994.04.011.
1994-12-30
1994-12-30